Prescient Therapeutics (ASX: PTX) CEO Steven Yatomi-Clarke recently presented at the AusBiotech Investment Conference 2021.
Steven introduced Prescient Therapeutics to a new range of investors, touching on results of the recent PTX100 study and explaining our next-gen CAR-T platform, OmniCAR.
Watch the presentation below.